Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022;24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069. Policy Forum Sep 2005 Presumed vs Expressed Consent in the US and Internationally Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe Virtual Mentor. 2005;7(9):610-614. doi: 10.1001/virtualmentor.2005.7.9.pfor2-0509. Viewpoint Sep 2005 Should Alcoholics Be Deprioritized for Liver Transplantation? Fritz Allhoff Virtual Mentor. 2005;7(9):634-637. doi: 10.1001/virtualmentor.2005.7.9.oped1-0509. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Policy Forum Nov 2022 Necessity for and Limitations of Price Transparency in American Health Care Harold A. Pollack, PhD, MPP More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline. AMA J Ethics. 2022;24(11):E1069-1074. doi: 10.1001/amajethics.2022.1069.
Policy Forum Sep 2005 Presumed vs Expressed Consent in the US and Internationally Sheldon Zink, PhD, Rachel Zeehandelaar, and Stacey Wertlieb, MBe Virtual Mentor. 2005;7(9):610-614. doi: 10.1001/virtualmentor.2005.7.9.pfor2-0509.
Viewpoint Sep 2005 Should Alcoholics Be Deprioritized for Liver Transplantation? Fritz Allhoff Virtual Mentor. 2005;7(9):634-637. doi: 10.1001/virtualmentor.2005.7.9.oped1-0509.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.